Skip to content
Recall Observatory FDA recall evidence

Drug product

Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2997-3; UPC # 360505299737;

D-1436-2016

January 26, 2016

Class III

Product summary

Firm
Apotex Scientific, Inc
Event
Event 73419
Status
Terminated
Classification
Class III
Quantity
605,989 (30 ct) bottles
Official record key
drug-enforcement:D-1436-2016

Official wording

Reason: Failed Dissolution Specification: Out of specification dissolution results when testing product stability.

Code information: Lot #: KW2167,KY9960, KV9789, KV9788; Exp 02/29/2016; Lot #: KY9961, Exp 04/30/2016; Lot #: KX6311, KX6312, KY7795, KX6315, Exp 05/31/2016; Lot #: KX6317, Exp 06/30/2016.

Distribution pattern: Nationwide, Alaska, Hawaii, and Puerto Rico.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification